MCR-1 and OXA-48 In Vivo Acquisition in KPC-Producing Escherichia coli after Colistin Treatment - Microbes, Intestin, Inflammation et Susceptibilité de l'Hôte Accéder directement au contenu
Article Dans Une Revue Antimicrobial Agents and Chemotherapy Année : 2017

MCR-1 and OXA-48 In Vivo Acquisition in KPC-Producing Escherichia coli after Colistin Treatment

Résumé

The spread of mcr-1-encoding plasmids into carbapenem-resistant En-terobacteriaceae raises concerns about the emergence of untreatable bacteria. We report the acquisition of mcr-1 in a carbapenem-resistant Escherichia coli strain after a 3-week course of colistin in a patient repatriated to France from Portugal. Whole-genome sequencing revealed that the Klebsiella pneumoniae carbapenemase-producing E. coli strain acquired two plasmids, an IncL OXA-48-encoding plasmid and an IncX4 mcr-1-encoding plasmid. This is the first report of mcr-1 in carbapenemase-encoding bacteria in France.
Fichier principal
Vignette du fichier
e02540-16.full.pdf (169.51 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-01639753 , version 1 (15-11-2018)

Licence

Copyright (Tous droits réservés)

Identifiants

Citer

Racha Beyrouthy, Frédéric Robin, Aude Lessene, Igor Lacombat, Laurent Dortet, et al.. MCR-1 and OXA-48 In Vivo Acquisition in KPC-Producing Escherichia coli after Colistin Treatment. Antimicrobial Agents and Chemotherapy, 2017, 61 (8), pp.e02540-16. ⟨10.1128/AAC.02540-16⟩. ⟨hal-01639753⟩
142 Consultations
180 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More